NDC Compounded Drug 73702-146-61 Nicotinamide Riboside Chloride
Injection, Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Nicotinamide Riboside Chloride
NDC crossover of Nicotinamide Riboside Chloride 500 Mg with NDC 73702-146 a human compounded drug with other similar products matching the same substance name (Nicotinamide Riboside Chloride) and the same administration route (intravenous) or dosage form (injection, solution).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 73702-144-60 | Nicotinamide Riboside Chloride 100 Mg | Nicotinamide Riboside Chloride 100 Mg | 5 mL in 1 VIAL, GLASS | Injection, Solution | Intravenous | Wells Pharma Of Houston |
| 73702-144-60 | Nicotinamide Riboside Chloride 100 Mg | Nicotinamide Riboside Chloride 100 Mg | 5 mL in 1 VIAL, GLASS | Injection, Solution | Intravenous | Wells Pharma Of Houston |
Frequently Asked Questions
What is the NDC number assigned to Nicotinamide Riboside Chloride 100 Mg?
Nicotinamide Riboside Chloride 100 Mg was assigned by its manufacturer with NDC product code 73702-146. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Nicotinamide Riboside Chloride 100 Mg?
The NDC package code 73702-146-61 was assigned to a 5 mL in 1 VIAL, GLASS of nicotinamide riboside chloride administered intravenous via injection, solution.
Who manufactures this product?
Nicotinamide Riboside Chloride 100 Mg is manufactured by an outsourced facility and labeled by Wells Pharma Of Houston. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Wells Pharma of Houston with NDC product codes 73702-144-60 and 73702-144-60.